Cardinal Health (NYSE:CAH) reported its second-quarter earnings for fiscal year 2024, surpassing analyst expectations with an ...

Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, ...

Baird raised the firm’s price target on Cardinal Health (CAH) to $154 from $149 and keeps an Outperform rating on the shares. Invest with ...

Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.

Hello, and welcome to the Second Quarter Fiscal Year 2025 Cardinal Health Inc. Earnings Conference Call. My name is George, and I'll be coordinator for today's event. Please note, this conference is ...

(CAH) on Thursday reported fiscal second-quarter earnings of $400 million. The Dublin, Ohio-based company said it had net income of $1.65 per share. Earnings, adjusted for one-time gains and costs, ...

The HRRMC (Heart of the Rockies Regional Medical Center) Board of Directors held its first meeting with new HRRMC President ...

Cardinal Health Inc (CAH) stock saw a decline, ending the day at $127.73 which represents a decrease of $-3.00 or -2.29% from the prior close of $130.73. The stock opened at $130.84 and touched a low ...

Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...

Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.

Despite rampant calls for members of Congress to refrain from active stock market investing while they are in office, members of both political parties remain routinely invested in the markets and re ...